Aislinn Antrim is managing editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and received her master’s in communication and media at Rutgers University in 2023.
FDA Approves Tivozanib for Treatment of Relapsed or Refractory Advanced Renal Cell Carcinoma
March 11th 2021The oral, next-generation vascular endothelial growth factor tyrosine kinase inhibitor is the first therapy approved for this patient population following 2 or more prior systemic therapies.
Read More
Medication Adherence in Pregnant Women With MS Can Reduce Hospitalizations
March 8th 2021Study findings demonstrate the importance of interventions for multiple sclerosis therapy, such as those supporting medication adherence, adverse effect management, symptom management, and additional counseling.
Read More
Most Humans Are Vulnerable to Type 2 Diabetes, Study Results Show
March 4th 2021Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.
Read More
FDA Approves Emergency Use Authorization for Johnson & Johnson Single-Dose COVID-19 Vaccine
February 28th 2021Approximately 2 million doses of Johnson & Johnson's single-dose COVID-19 vaccine are ready to ship and supply is expected to sharply increase, with up to 20 million doses available by the end of March.
Read More